Search Results - "Salvador Garrido, P"

Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients: Abstract# D2439 by Salvador-Garrido, P., Outeda-Macias, M., Pedreira-Vazquez, I., Elberdin-Pazos, L., Fernandez-Rivera, C., Alonso-Hernandez, A., Martin-Herranz, I.

Get full text

Impact of Omeprazole On Mycophenolic Acid Pharmacokinetics in Adult Renal Transplant Patients: Abstract# C1785 by Fernandez-Rivera, C., Salvador-Garrido, P., Outeda-Macias, M., Pedreira-Vazquez, I., Elberdin-Pazos, L., Alonso-Hernandez, A., Martin-Herranz, I.

Get full text

Limited Sampling Strategy to Determine the Degree of Exposure to Mycophenolic Acid after Enteric- Coated Mycophenolate Sodium in Renal Transplant Adult Patients: 2083 by Salvador Garrido, P., Outeda Macias, M., Pedreira Vázquez, I., Seoane Pillado, T., Fernández Rivera, C., Alonso Hernández, A., López Muñiz, A., Martín Herranz, I.

Get full text

Limited Sampling Strategy to Determine the Degree of Exposure to Mycophenolic Acid after Mycophenolate Mofetil in Renal Transplant Adult Patients: 2085 by Outeda Macias, M., Salvador Garrido, P., Pedreira Vázquez, I., Seoane Pillado, T., Fernández Rivera, C., Alonso Hernández, A., López Muñiz, A., Martín Herranz, I.

Get full text

Degree of Exposure to Mycophenolic Acid in Renal Transplant Adult Patients: 2084 by Salvador Garrido, P., Outeda Macias, M., Pedreira Vázquez, I., Seoane Pillado, T., Alonso Hernández, A., López Muñiz, A., Fernández Rivera, C., Martín Herranz, I.

Get full text

Assessment of safety practices for medication-use systems in Spanish hospitals (2007) by Otero López, M J, Martín Muñoz, M R, Castaño Rodríguez, B, Palomo Cobos, L, Cajaraville Ordoñana, G, Codina Jané, C, Martínez Cutillas, J, Pérez Encinas, M, Salvador Garrido, P, Santos Rubio, M D

“…To examine the current status of safety practices for medication-use systems in Spanish hospitals and to identify major areas of risk. Those hospitals that…”
Get more information

Treatment with oral or topical sirolimus in complex vascular anomalies in pediatrics. Experience in a third-level hospital by Fernández Oliveira, C, Martínez Roca, C, Gómez Tellado, M, Salvador Garrido, M P, Outeda Macías, M, Martín Herranz, I

“…The use of sirolimus in vascular anomalies is a special indication not authorized in its data sheet. The objective of this study was to increase the evidence…”
Get more information